Biological actions of artemisinin: Insights from medicinal chemistry studies

Molecules

Volumn 15, Issue 3, 2010, Pages 1378-1397

  Li, Jian ^a   Zhou, Bing ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

Artemisinin; Heme; Iron; Mitochondria; PfATP6

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; ARTEMISININ DERIVATIVE; IRON;

ANIMAL; ARTICLE; CHEMISTRY; DRUG EFFECT; PLASMODIUM FALCIPARUM; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIMALARIALS; ARTEMISININS; IRON; PLASMODIUM FALCIPARUM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77950362820     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15031378     Document Type: Article

References (114)

1. Enserink, M. Epidemiology: Lower malaria numbers reflect better estimates and a glimmer of hope. Science 2008, 321, 1620.
2. ter Kuile, F.; White, N. J.; Holloway, P.; Pasvol, G.; Krishna, S. Plasmodium falciparum: In vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. Exp. Parasitol. 1993, 76, 85-95.
3. Sen, R.; Bandyopadhyay, S.; Dutta, A.; Mandal, G.; Ganguly, S.; Saha, P.; Chatterjee, M. Artemisinin triggers induction of cell-cycle arrest and apoptosis in Leishmania donovani promastigotes. J. Med. Microbiol. 2007, 56, 1213-1218.
4. Utzinger, J.; N'Goran, E. K.; N'Dri, A.; Lengeler, C.; Xiao, S.; Tanner, M. Oral artemether for prevention of Schistosoma mansoni infection: Randomised controlled trial. Lancet 2000, 355, 1320-1325.
5. Utzinger, J.; Xiao, S. H.; Tanner, M.; Keiser, J. Artemisinins for schistosomiasis and beyond. Curr. Opin. Investig. Drugs 2007, 8, 105-116.
6. Jones-Brando, L.; D'Angelo, J.; Posner, G. H.; Yolken, R. In vitro inhibition of Toxoplasma gondii by four new derivatives of artemisinin. Antimicrob. Agents Chemother. 2006, 50, 4206-4208.
7. Dunay, I. R.; Chan, W. C.; Haynes, R. K.; Sibley, L. D. Artemisone and artemiside control acute and reactivated toxoplasmosis in a murine model. Antimicrob. Agents Chemother. 2009, 53, 4450-4456.
8. Romero, M. R.; Serrano, M. A.; Vallejo, M.; Efferth, T.; Alvarez, M.; Marin, J. J. Antiviral effect of artemisinin from Artemisia annua against a model member of the Flaviviridae family, the bovine viral diarrhoea virus (BVDV). Planta Med. 2006, 72, 1169-1174.
9. Willoughby, J. A., Sr.; Sundar, S. N.; Cheung, M.; Tin, A. S.; Modiano, J.; Firestone, G. L. Artemisinin blocks prostate cancer growth and cell cycle progression by disrupting Sp1 interactions with the cyclin-dependent kinase-4 (CDK4) promoter and inhibiting CDK4 gene expression. J. Biol. Chem. 2009, 284, 2203-2213.
10. Li, P. C.; Lam, E.; Roos, W. P.; Zdzienicka, M. Z.; Kaina, B.; Efferth, T. Artesunate derived from traditional Chinese medicine induces DNA damage and repair. Cancer Res. 2008, 68, 4347-4351.
11. Svensson, U. S.; Ashton, M. Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin. Br. J. Clin. Pharmacol. 1999, 48, 528-535.
12. The Qinghaosu Antimalarial Coordinating Research Group. Antimalaria studies on Qinghaosu (English). Chin. Med. J. 1979, 92, 811-816.
13. Rosenthal, A. S.; Chen, X.; Liu, J. O.; West, D. C.; Hergenrother, P. J.; Shapiro, T. A.; Posner, G. H. Malaria-infected mice are cured by a single oral dose of new dimeric trioxane sulfones which are also selectively and powerfully cytotoxic to cancer cells. J. Med. Chem. 2009, 52, 1198-1203.
14. Woodard, L. E.; Chang, W.; Chen, X.; Liu, J. O.; Shapiro, T. A.; Posner, G. H. Malaria-infected mice live until at least day 30 after a new monomeric trioxane combined with mefloquine are administered together in a single low oral dose. J. Med. Chem. 2009, 52, 7458-7462.
15. The Research Group of Artemisinin Structure. A new sesquiterpene lactone-artemisinin. Chin. Sci. Bull. 1977, 22, 142.
16. Xu, X. X.; Zhu, J.; Huang, D.; Zhou, W. S. Studies on structure and syntheses of arteannuin and related compound X. The stereocontrolled syntheses of arteannuin and deoxyarteannuin from arteannuic acid. Acta Chim. Sinica 1983, 41, 574-576.
17. Schmid, G.; Hofheinz, W. Total synthesis of qinghaosu. J. Am. Chem. Soc. 1983, 105, 624-625.
18. Tsuruta, H.; Paddon, C. J.; Eng, D.; Lenihan, J. R.; Horning, T.; Anthony, L. C.; Regentin, R.; Keasling, J. D.; Renninger, N. S.; Newman, J. D. High-level production of amorpha-4, 11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coli. PLoS One 2009, 4, e4489.
19. Arsenault, P. R.; Wobbe, K. K.; Weathers, P. J. Recent advances in artemisinin production through heterologous expression. Curr. Med. Chem. 2008, 15, 2886-2896.
20. Wu, J. A.; Ji, R. Y. A quantitative structure-activity study on artemisinine analogues. Acta Pharmacol. Sin. 1982, 3, 55-60.
21. Meshnick, S. R.; Taylor, T. E.; Kamchonwongpaisan, S. Artemisinin and the antimalarial endoperoxides: From herbal remedy to targeted chemotherapy. Microbiol. Rev. 1996, 60, 301-315.
22. Lin, A. J.; Klayman, D. L. Thermal rearrangement and decomposition products of artemisinin (qinghaosu). J. Org. Chem. 1985, 50, 4504-4508.
23. Liu, J. M.; Ni, M. Y.; Fan, J. F.; Tu, Y. Y. Structure and reaction of arteannuin. Acta Chimica Sinica 1979, 37, 129-140.
24. Zhou, W. S.; Wen, Y. C. Studies on structure and synthesis of arteannuin and its related compounds. VI the structures of arteannuin degradation products. Acta Chim. Sin. 1984, 42, 455-459.
25. Liu, J. M.; Ni, M. Y.; Fan, J. F.; Tu, Y. Y. Structure and reaction of arteannuin. Acta Chim. Sin. 1979, 37, 129-141.
26. Li, Y.; Yu, P. L.; Chen, Y. X. Studies on analoges of qinghaosu-some acidic degradations of qinghaosu (English). Kexue Tongbao 1986, 31, 1038-1040.
27. Levander, O. A.; Ager, A. L., Jr.; Morris, V. C.; May, R. G. Qinghaosu, dietary vitamin E, selenium, and cod-liver oil: Effect on the susceptibility of mice to the malarial parasite Plasmodium yoelii. Am. J. Clin. Nutr. 1989, 50, 346-352.
28. Meshnick, S. R.; Tsang, T. W.; Lin, F. B.; Pan, H. Z.; Chang, C. N.; Kuypers, F.; Chiu, D.; Lubin, B. Activated oxygen mediates the antimalarial activity of qinghaosu. Prog. Clin. Biol. Res. 1989, 313, 95-104.
29. Slater, A. F. Malaria pigment. Exp. Parasitol. 1992, 74, 362-365.
30. Meshnick, S. R.; Thomas, A.; Ranz, A.; Xu, C. M.; Pan, H. Z. Artemisinin (qinghaosu) : The role of intracellular hemin in its mechanism of antimalarial action. Mol. Biochem. Parasitol. 1991, 49, 181-189.
31. Zhang, F.; Gosser, D. K., Jr.; Meshnick, S. R. Hemin-catalyzed decomposition of artemisinin (qinghaosu). Biochem. Pharmacol. 1992, 43, 1805-1809.
32. Meshnick, S. R.; Yang, Y. Z.; Lima, V.; Kuypers, F.; Kamchonwongpaisan, S.; Yuthavong, Y. Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu). Antimicrob. Agents Chemother. 1993, 37, 1108-1114.
33. Posner, G. H.; Oh, C. H. A Regiospecifically O-18 Labeled 1,2,4-trioxane, a simple chemical-model system to probe the mechanism (s) for the antimalarial activity of artemisinin Qinghaosu). J. Am. Chem. Soc. 1992, 114, 8328-8329.
34. O'Neill, P. M.; Posner, G. H. A medicinal chemistry perspective on artemisinin and related endoperoxides. J. Med. Chem. 2004, 47, 2945-2964.
35. Golenser, J.; Domb, A.; Leshem, B.; Kremsner, P.; Luty, A. Iron chelators as drugs against malaria pose a potential risk. Redox Rep. 2003, 8, 268-271.
36. Hong, Y. L.; Yang, Y. Z.; Meshnick, S. R. The interaction of artemisinin with malarial hemozoin. Mol. Biochem. Parasitol. 1994, 63, 121-128.
37. Cheng, F.; Shen, J.; Luo, X.; Zhu, W.; Gu, J.; Ji, R.; Jiang, H.; Chen, K. Molecular docking and 3-D-QSAR studies on the possible antimalarial mechanism of artemisinin analogues. Bioorg. Med. Chem. 2002, 10, 2883-2891.
38. Posner, G. H.; Wang, D.; Cumming, J. N.; Oh, C. H.; French, A. N.; Bodley, A. L.; Shapiro, T. A. Further evidence supporting the importance of and the restrictions on a carbon-centered radical for high antimalarial activity of 1,2,4-trioxanes like artemisinin. J. Med. Chem. 1995, 38, 2273-2275.
39. Kamchonwongpaisan, S.; Meshnick, S. R. The mode of action of the antimalarial artemisinin and its derivatives. Gen. Pharmacol. 1996, 27, 587-592.
40. Sibmooh, N.; Udomsangpetch, R.; Kujoa, A.; Chantharaksri, U.; Mankhetkorn, S. Redox reaction of artemisinin with ferrous and ferric ions in aqueous buffer. Chem. Pharm. Bull. (Tokyo) 2001, 49, 1541-1546.
41. Eckstein-Ludwig, U.; Webb, R. J.; Van Goethem, I. D.; East, J. M.; Lee, A. G.; Kimura, M.; O'Neill, P. M.; Bray, P. G.; Ward, S. A.; Krishna, S. Artemisinins target the SERCA of Plasmodium falciparum. Nature 2003, 424, 957-961.
42. Stocks, P. A.; Bray, P. G.; Barton, V. E.; Al-Helal, M.; Jones, M.; Araujo, N. C.; Gibbons, P.; Ward, S. A.; Hughes, R. H.; Biagini, G. A.; Davies, J.; Amewu, R.; Mercer, A. E.; Ellis, G.; O'Neill, P. M. Evidence for a common non-heme chelatableiron-dependent activation mechanism for semisynthetic and synthetic endoperoxide antimalarial drugs. Angew. Chem. Int. Ed. Engl. 2007, 46, 6278-6283.
43. Haynes, R. K.; Ho, W. Y.; Chan, H. W.; Fugmann, B.; Stetter, J.; Croft, S. L.; Vivas, L.; Peters, W.; Robinson, B. L. Highly antimalaria-active artemisinin derivatives: Biological activity does not correlate with chemical reactivity. Angew. Chem. Int. Ed. Engl. 2004, 43, 1381-1385.
44. Morel, I.; Cillard, J.; Lescoat, G.; Sergent, O.; Pasdeloup, N.; Ocaktan, A. Z.; Abdallah, M. A.; Brissot, P.; Cillard, P. Antioxidant and free radical scavenging activities of the iron chelators pyoverdin and hydroxypyrid-4-ones in iron-loaded hepatocyte cultures: Comparison of their mechanism of protection with that of desferrioxamine. Free Radic Biol. Med. 1992, 13, 499-508.
45. Barbouti, A.; Doulias, P. T.; Zhu, B. Z.; Frei, B.; Galaris, D. Intracellular iron, but not copper, plays a critical role in hydrogen peroxide-induced DNA damage. Free Radic Biol. Med. 2001, 31, 490-498.
46. Haynes, R. K.; Pai, H. H. O.; Voerste, A. Ring opening of artemisinin (qinghaosu) and dihydroartemisinin and interception of the open hydroperoxideswith formation of N-oxides-A chemicalmodel for antimalarialmode of action. Tetrahedron Lett. 1999, 40, 4715-4718.
47. Haynes, R. K.; Vonwiller, S. C. The behaviour of qinghaosu (artemisinin) in the presence of non-heme Iron (II) and (III). Tetrahedron Lett. 1996, 37, 257-260.
48. Haynes, R. K.; Chan, W. C.; C.-M. Lung; Uhlemann, A.-C.; Eckstein, U.; Taramelli, D.; Parapini, S.; Monti, D.; Krishna, S. The Fe2-mediated decomposition, PfATP6 binding, and antimalarial activities of artemisone and other artemisinins: The unlikelihood of C-entered radicals as bioactive intermediates. ChemMedChem 2007, 2, 1480-1497.
49. Posner, G. H.; Parker, M. H.; Northrop, J.; Elias, J. S.; Ploypradith, P.; Xie, S.; Shapiro, T. A. Orally active, hydrolytically stable, semisynthetic, antimalarial trioxanes in the artemisinin family. J. Med. Chem. 1999, 42, 300-304.
50. O'Neill, P. M.; Searle, N. L.; Kan, K. W.; Storr, R. C.; Maggs, J. L.; Ward, S. A.; Raynes, K.; Park, B. K. Novel, potent, semisynthetic antimalarial carba analogues of the first-generation 1,2,4-trioxane artemether. J. Med. Chem. 1999, 42, 5487-5493.
51. Ma, J.; Weiss, E.; Kyle, D. E.; Ziffer, H. Acid catalyzed Michael additions to artemisitene. Bioorg. Med. Chem. Lett. 2000, 10, 1601-1603. (Pubitemid 30449730)
52. Jung, M.; Lee, K.; Jung, H. First synthesis of (1) -deoxoartemisitene and its novel C-11 derivatives. Tetrahedron Lett. 2001, 42, 3997-4000. (Pubitemid 32510773)
53. Jefford, C. W.; McGoran, E. C.; Boukouvalas, J.; Richardson, G.; Robinson, B. L.; Peters, W. Synthesis of new 1,2,4-trioxanes and their antimalarial activity. Helv. Chim. Acta 1988, 1805-1812.
54. Jefford, C. W.; Velarde, J. A.; Bernardinelli, G.; Bray, D. H.; Warhurst, D. C.; Milhous, W. K. Synthesis, structure, and antimalarial activity of tricyclic 1,2,4-trioxanes related to artemisinin. Helv. Chim. Acta 1993, 76, 2775-2788. (Pubitemid 24013744)
55. Kepler, J. A.; Philip, A.; Lee, Y. W.; Musallam, H. A.; Carroll, F. I. Endoperoxides as potential antimalarial agents. J. Med. Chem. 1987, 30, 1505-1509.
56. Borstnik, K.; Paik, I. H.; Shapiro, T. A.; Posner, G. H. Antimalarial chemotherapeutic peroxides: Artemisinin, yingzhaosu A and related compounds. Int. J. Parasitol. 2002, 32, 1661-1667. (Pubitemid 35336007)
57. Vennerstrom, J. L.; Fu, H. N.; Ellis, W. Y.; Ager, A. L., Jr.; Wood, J. K.; Andersen, S. L.; Gerena, L.; Milhous, W. K. Dispiro-1, 2,4,5-tetraoxanes: A new class of antimalarial peroxides. J. Med. Chem. 1992, 35, 3023-3027.
58. Peters, W.; Robinson, B. L.; Rossier, J. C.; Jefford, C. W. The chemotherapy of rodent malaria. XLVIII. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine-resistant parasites. Part 1: Studies leading to the development of novel cis-fused cyclopenteno derivatives. Ann. Trop. Med. Parasitol. 1993, 87, 1-7. (Pubitemid 23147453)
59. Peters, W.; Robinson, B. L.; Rossier, J. C.; Misra, D.; Jefford, C. W.; Rossiter, J. C. The chemotherapy of rodent malaria. XLIX. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine-resistant parasites. Part 2: Structure-activity studies on cis-fused cyclopenteno-1,2,4-trioxanes (fenozans) against drug-sensitive and drug-resistant lines of Plasmodium berghei and P. yoelii ssp. NS in vivo. Ann. Trop. Med. Parasitol. 1993, 87, 9-16. (Pubitemid 23147454)
60. Vennerstrom, J. L.; Dong, Y.; Andersen, S. L.; Ager, A. L., Jr.; Fu, H.; Miller, R. E.; Wesche, D. L.; Kyle, D. E.; Gerena, L.; Walters, S. M.; Wood, J. K.; Edwards, G.; Holme, A. D.; McLean, W. G.; Milhous, W. K. Synthesis and antimalarial activity of sixteen dispiro-1, 2,4,5-tetraoxanes: Alkyl-substituted 7, 8, 15, 16-tetraoxadispiro[5.2.5.2]hexadecanes. J. Med. Chem. 2000, 43, 2753-2758. (Pubitemid 30463924)
61. Posner, G. H.; Jeon, H. B.; Parker, M. H.; Krasavin, M.; Paik, I. H.; Shapiro, T. A. Antimalarial simplified 3-aryltrioxanes: Synthesis and preclinical efficacy/toxicity testing in rodents. J. Med. Chem. 2001, 44, 3054-3058.
62. Posner, G. H.; Cumming, J. N.; Woo, S. H.; Ploypradith, P.; Xie, S.; Shapiro, T. A. Orally active antimalarial 3-substituted trioxanes: New synthetic methodology and biological evaluation. J. Med. Chem. 1998, 41, 940-951.
63. Vennerstrom, J. L.; Arbe-Barnes, S.; Brun, R.; Charman, S. A.; Chiu, F. C.; Chollet, J.; Dong, Y.; Dorn, A.; Hunziker, D.; Matile, H.; McIntosh, K.; Padmanilayam, M.; Santo Tomas, J.; Scheurer, C.; Scorneaux, B.; Tang, Y.; Urwyler, H.; Wittlin, S.; Charman, W. N. Identification of an antimalarial synthetic trioxolane drug development candidate. Nature 2004, 430, 900-904.
64. O'Neill, P. M.; Rawe, S. L.; Borstnik, K.; Miller, A.; Ward, S. A.; Bray, P. G.; Davies, J.; Oh, C. H.; Posner, G. H. Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: Implications for the molecular mechanism of action of the artemisinins. ChemBioChem 2005, 6, 2048-2054.
65. Jefford, C. W. Synthesis, structure, and antimalarial activity of some enantiomerically pure, cis-fused cyclopenteno-1,2,4-trioxanes. Helv. Chim. Acta 1995, 78, 647-662.
66. Najjar, F.; Gorrichon, L.; Baltas, M.; Andre-Barres, C.; Vial, H. Alkylation of natural endoperoxide G3-factor. Synthesis and antimalarial activity studies. Org. Biomol. Chem. 2005, 3, 1612-1614.
67. Joris, J.; Costello, A.; Dubner, R.; Hargreaves, K. M. Opiates suppress carrageenan-induced edema and hyperthermia at doses that inhibit hyperalgesia. Pain 1990, 43, 95-103.
68. Olliaro, P. L.; Haynes, R. K.; Meunier, B.; Yuthavong, Y. Possible modes of action of the artemisinin-type compounds. Trends Parasitol. 2001, 17, 122-126.
69. del Pilar Crespo, M.; Avery, T. D.; Hanssen, E.; Fox, E.; Robinson, T. V.; Valente, P.; Taylor, D. K.; Tilley, L. Artemisinin and a series of novel endoperoxide antimalarials exert early effects on digestive vacuole morphology. Antimicrob. Agents Chemother. 2008, 52, 98-109.
70. Jung, M.; Kim, H.; Nam, K. Y.; No, K. T. Three-dimensional structure of Plasmodium falciparum Ca2+ -ATPase (PfATP6) and docking of artemisinin derivatives to PfATP6. Bioorg. Med. Chem. Lett. 2005, 15, 2994-2997.
71. Garah, F. B.; Stigliani, J. L.; Cosledan, F.; Meunier, B.; Robert, A. Docking studies of structurally diverse antimalarial drugs targeting PfATP6: No correlation between in silico binding affinity and in vitro antimalarial activity. ChemMedChem 2009, 4, 1469-1479.
72. Uhlemann, A. C.; Cameron, A.; Eckstein-Ludwig, U.; Fischbarg, J.; Iserovich, P.; Zuniga, F. A.; East, M.; Lee, A.; Brady, L.; Haynes, R. K.; Krishna, S. A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. Nat. Struct. Mol. Biol. 2005, 12, 628-629.
73. Jambou, R.; Legrand, E.; Niang, M.; Khim, N.; Lim, P.; Volney, B.; Ekala, M. T.; Bouchier, C.; Esterre, P.; Fandeur, T.; Mercereau-Puijalon, O. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet 2005, 366, 1960-1963.
74. Cojean, S.; Hubert, V.; Le Bras, J.; Durand, R. Resistance to dihydroartemisinin. Emerg. Infect. Dis. 2006, 12, 1798-1799.
75. Jefford, C. W. New developments in synthetic peroxidic drugs as artemisinin mimics. Drug Discov. Today 2007, 12, 487-495.
76. Robert, A.; Coppel, Y.; Meunier, B. Alkylation of heme by the antimalarial drug artemisinin. Chem. Comm. 2002, 414-415.
77. Pandey, A. V.; Tekwani, B. L.; Singh, R. L.; Chauhan, V. S. Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification systems in malarial parasite. J. Biol. Chem. 1999, 274, 19383-19388.
78. Robert, A.; Benoit-Vical, C.; Claparols, C.; Meunier, B. The antimalarial drug artemisinin alkylates heme in infected mice. Proc. Natl. Acad. Sci. 2005, 102, 13676-13680.
79. Kannan, R.; Kumar, K.; Sahal, D.; Kukreti, S.; Chauhan, V. S. Reaction of artemisinin with haemoglobin: Implications for antimalarial activity. Biochem. J. 2005, 385, 409-418.
80. Kannan, R.; Sahal, D.; Chauhan, V. S. Heme-artemisinin adducts are crucial mediators of the ability of artemisinin to inhibit heme polymerization. Chem. Biol. 2002, 9, 321-332.
81. Loup, C.; Lelievre, J.; Benoit-Vical, F.; Meunier, B. Trioxaquines and heme-artemisinin adducts inhibit the in vitro formation of hemozoin better than chloroquine. Antimicrob. Agents Chemother. 2007, 51, 3768-3770. (Pubitemid 47519376)
82. Francis, S. E.; Sullivan, D. J.; Goldberg, D. E. Hemoglobin metabolism in the malarial parasite Plasmodium falciparum. Annu. Rev. Microbiol. 1997, 51, 97-123. (Pubitemid 27433044)
83. Kaiser, M.; Wittlin, S.; Nehrbass-Stuedli, A.; Dong, Y.; Wang, X.; Hemphill, A.; Matile, H.; Brun, R.; Vennerstrom, J. L. Peroxide Bond-dependent antiplasmodial specificity of artemisinin and OZ277 (RBx11160). Antimicrob. Agents Chemother. 2007, 51, 2991-2993. (Pubitemid 47206243)
84. Elliott, D. A.; McIntosh, M. T.; Hosgood III, H. D.; Chen, S.; Zhang, G.; Baevova, P.; Joiner, K. A. Four distinct pathways of hemoglobin uptake in the malaria parasite Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 2008, 105, 2463-2468.
85. Paitayatat, S.; Tarnchompoo, B.; Thebtaranonth, Y.; Yuthavong, Y. Correlation of antimalarial activity of artemisinin derivatives with binding affinity with ferroprotoporphyrin IX. J. Med. Chem. 1997, 40, 633-638. (Pubitemid 27102568)
86. Peters, W.; Li, Z. L.; Robinson, B. L.; Warhurst, D. C. The chemotherapy of rodent malaria, XL. The action of artemisinin and related sesquiterpenes. Ann. Trop. Med. Parasitol. 1986, 80, 483-489.
87. Wittner, M.; Lederman, J.; Tanowitz, H. B.; Rosenbaum, G. S.; Weiss, L. M. Atovaquone in the treatment of Babesia microti infections in hamsters. Am. J. Trop. Med. Hyg. 1996, 55, 219-222. (Pubitemid 26299210)
88. Asawamahasakda, W.; Ittarat, I.; Chang, C. C.; McElroy, P.; Meshnick, S. R. Effects of antimalarials and protease inhibitors on plasmodial hemozoin production. Mol. Biochem. Parasitol. 1994, 67, 183-191. (Pubitemid 24330731)
89. Haynes, R. K.; Monti, D.; Taramelli, D.; Basilico, N.; Parapini, S.; Olliaro, P. Artemisinin antimalarials do not inhibit hemozoin formation. Antimicrob. Agents Chemother. 2003, 47, 1175. (Pubitemid 36254260)
90. Meshnick, S. R. Artemisinin and heme. Antimicrob. Agents Chemother. 2003, 47, 2712; author reply 2712-2713.
91. Coghi, P.; Basilico, N.; Taramelli, D.; Chan, W. C.; Haynes, R. K.; Monti, D. Interaction of Artemisinins with Oxyhemoglobin Hb-FeII, Hb-FeII, CarboxyHb-FeII, Heme-FeII, and Carboxyheme FeII: Significance for Mode of action and implications for therapy of cerebral malaria. Chem Med Chem 2009, 4, 2045-2053.
92. Asawamahasakda, W.; Ittarat, I.; Pu, Y. M.; Ziffer, H.; Meshnick, S. R. Reaction of antimalarial endoperoxides with specific parasite proteins. Antimicrob. Agents Chemother. 1994, 38, 1854-1858. (Pubitemid 24250737)
93. Bhisutthibhan, J.; Pan, X. Q.; Hossler, P. A.; Walker, D. J.; Yowell, C. A.; Carlton, J.; Dame, J. B.; Meshnick, S. R. The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin. J. Biol. Chem. 1998, 273, 16192-16198. (Pubitemid 28311392)
94. Chae, J.; Choi, I.; Kim, C. Homology modeling and molecular docking study of translationally controlled tumor protein and artemisinin. Arch. Pharm. Res. 2006, 29, 50-58.
95. Li, W.; Mo, W.; Shen, D.; Sun, L.; Wang, J.; Lu, S.; Gitschier, J. M.; Zhou, B. Yeast model uncovers dual roles of mitochondria in action of artemisinin. PLoS Genet. 2005, 1, e36.
96. Ginsburg, H.; Divo, A. A.; Geary, T. G.; Boland, M. T.; Jensen, J. B. Effects of mitochondrial inhibitors on intraerythrocytic Plasmodium falciparum in in vitro cultures. J. Protozool. 1986, 33, 121-125.
97. Srivastava, I. K.; Rottenberg, H.; Vaidya, A. B. Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite. J. Biol. Chem. 1997, 272, 3961-3966. (Pubitemid 27078454)
98. Hartwig, C. L.; Rosenthal, A. S.; D'Angelo, J.; Griffin, C. E.; Posner, G. H.; Cooper, R. A. Accumulation of artemisinin trioxane derivatives within neutral lipids of Plasmodium falciparum malaria parasites is endoperoxide-dependent. Biochem. Pharmacol. 2009, 77, 322-336.
99. Li, Z. L. Use of nuclear techniques in the study of the antimalarial action of Qinghaosu and dihydro-Qinghaosu. Nucl. Techniq. 1984, 2, 23-25.
100. Maeno, Y.; Toyoshima, T.; Fujioka, H.; Ito, Y.; Meshnick, S. R.; Benakis, A.; Milhous, W. K.; Aikawa, M. Morphologic effects of artemisinin in Plasmodium falciparum. Am. J. Trop. Med. Hyg. 1993, 49, 485-491.
101. Ellis, D. S.; Li, Z. L.; Gu, H. M.; Peters, W.; Robinson, B. L.; Tovey, G.; Warhurst, D. C. The chemotherapy of rodent malaria, XXXIX. Ultrastructural changes following treatment with artemisinine of Plasmodium berghei infection in mice, with observations of the localization of [3H]-dihydroartemisinine in P. falciparum in vitro. Ann. Trop. Med. Parasitol. 1985, 79, 367-374.
102. Jiang, J. B.; Jacobs, G.; Liang, D. S.; Aikawa, M. Qinghaosu-induced changes in the morphology of Plasmodium inui. Am. J. Trop. Med. Hyg. 1985, 34, 424-428.
103. Kawai, S.; Kano, S.; Suzuki, M. Morphologic effects of artemether on Plasmodium falciparum in Aotus trivirgatus. Am. J. Trop. Med. Hyg. 1993, 49, 812-818. (Pubitemid 24021783)
104. Dondorp, A. M.; Nosten, F.; Yi, P.; Das, D.; Phyo, A. P.; Tarning, J.; Lwin, K. M.; Ariey, F.; Hanpithakpong, W.; Lee, S. J.; Ringwald, P.; Silamut, K.; Imwong, M.; Chotivanich, K.; Lim, P.; Herdman, J.; An, S. S.; Yeung, S.; Singhasivanon, P.; Day, N. P.; Lindegardh, N.; Socheat, D. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 2009, 361, 455-467.
105. Noedl, H.; Se, Y.; Schaecher, K.; Smith, B. L.; Socheat, D.; Fukuda, M. M. Evidence of artemisinin-resistant malaria in western Cambodia. N. Engl. J. Med. 2008, 359, 2619-2620.
106. Noedl, H.; Socheat, D.; Satimai, W. Artemisinin-resistant malaria in Asia. N. Engl. J. Med. 2009, 361, 540-541.
107. Huang, Q.; Zhou, B. Exploring artemisinins protein targets in yeast. J. Tsinghua Univ. (Sci. &Tech.) 2008, 43, 408-411.
108. Price, R. N.; Uhlemann, A. C.; Brockman, A.; McGready, R.; Ashley, E.; Phaipun, L.; Patel, R.; Laing, K.; Looareesuwan, S.; White, N. J.; Nosten, F.; Krishna, S. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 2004, 364, 438-447.
109. Sidhu, A. B.; Verdier-Pinard, D.; Fidock, D. A. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 2002, 298, 210-213.
110. Pickard, A. L.; Wongsrichanalai, C.; Purfield, A.; Kamwendo, D.; Emery, K.; Zalewski, C.; Kawamoto, F.; Miller, R. S.; Meshnick, S. R. Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. Antimicrob. Agents Chemother. 2003, 47, 2418-2423.
111. Afonso, A.; Hunt, P.; Cheesman, S.; Alves, A. C.; Cunha, C. V.; do Rosario, V.; Cravo, P. Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2+ ATPase), tctp, mdr1, and cg10. Antimicrob. Agents Chemother. 2006, 50, 480-489.
112. Inselburg, J. Induction and isolation of artemisinine-resistant mutants of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 1985, 34, 417-418.
113. Peters, W.; Robinson, B. L. The chemotherapy of rodent malaria. LVI. Studies on the development of resistance to natural and synthetic endoperoxides. Ann. Trop. Med. Parasitol. 1999, 93, 325-329.
114. Meshnick, S. R. Artemisinin: Mechanisms of action, resistance and toxicity. Int. J. Parasitol. 2002, 32, 1655-1660.